课题基金 / 基金详情

Regulation of the Expression of CD45 alternative Structures in Lymphocyte Subsets

Regulation of the Expression of CD45 alternative Structures in Lymphocyte Subsets
淋巴细胞亚群中 CD45 替代结构表达的调节
批准号:
05670309
负责人:
NISHIMURA Hiroyuki
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

NISHIMURA Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD45 is a family of membrane-integral protein tyrosine phosphatase thought to be involved in the regulation of signal transduction in lymphocyte. Outer-membrane domain of the molecule has three alternative structures, and eight isoforms are generated by the alternative splicing of exons 4,5 and 6. We analyzed the differential expression of tree CD45 alternative structures (CD45RA,B and C) of mouse CD45 in relation to the ontogeny and differentiation of lymphocyte subsets. The results are summarized as followsB cells : While peripheral B cells were all CD45RA+B+C+, there were differential expressions of these epitopes on bone marrow B lineage cells. Although three alternative CD 45 epitopes began to be expressed at an early stage of pre B cells, the process of each epitope expression differed ; while the expression of CD45RA and CD45RC nearly coincided, CD45RB expression was markedly delayd. Since all three alternative CD45 mRNA expressions occurred at an early pre B cell stage, and pro … More gressively elevated in subsequent developmental stages, the observed delay in the CD45RB expression appeared to be due to post-translational eventsCD4+ T cells : Splenic CD4+ T cells included two populations, CD45RA-B+C- and CD45RA-B+C+. In these cells, messages of alternative exons were associated with either Bone (exon 4 or exon 5) or two exon form (exon 5 and exon 6) of the CD45 transcript.When stimulated by an immobilized CD3 mAb, the CD45RC+CD4+ T cells secreted IL-2 but not other cytokines such as IL-4, IFN-g or IL-10, thereby represented "naive" ThP-type cells. CD45RC-CD4+ T cells produced IL-2, IL-4, IFN-g and IL-10 and likely included both Th1- and Th2-type cells.CD8+ T cells : Splenic CD8+ T cells were separated into CD45RA-B+C+ and CD45RA+B+C+. There were transcripts with one, two, or three alternative exons suggesting that these cells express various types of CD45 isoforms including the largest form with all three alternative structures. Studies on T cell clones established in vitro revealed that while cytotoxic CD8+ T cells clones were CD45RA+, suppressor effecter CD8+ T cell clones were CD45RA-. Further studies on the functional difference between CD45RA-CD8+ T cells and CD45RA+CD8+ T cells are in progress. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
H.Nishimura et al.: "Differential expression of three CD45 alternative structures on murine T cells" Int.Immunol.4. 923-930 (1992)
H.Nishimura 等人:“小鼠 T 细胞上三种 CD45 替代结构的差异表达”Int.Immunol.4。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue T,Asano Y,Matsuoka Furutani-Seiki M,Aizawa S,Nishimura H,Shirai T,Tada T:"Distinction of mouse CD8^+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms." J.Immunol.150. 2121-2128 (1993)
Inoue T、Asano Y、Matsuoka Furutani-Seiki M、Aizawa S、Nishimura H、Shirai T、Tada T:“通过细胞因子产生和 CD45 亚型区分小鼠 CD8^ 抑制效应 T 细胞克隆与细胞毒性 T 细胞克隆。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue,T.et al.: "Distinction of mouse CD8^+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms." J.Immunol.150. 2121-2128 (1993)
Inoue,T.et al.:“通过细胞因子产生和 CD45 亚型区分小鼠 CD8^ 抑制效应 T 细胞克隆与细胞毒性 T 细胞克隆。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Nishimura et al.: "Differential expression of a CD45R epitope(6B2)on murine CD5+ B cells" Cell.Immunol.140. 432-443 (1992)
H.Nishimura 等人:“鼠 CD5 B 细胞上 CD45R 表位 (6B2) 的差异表达”Cell.Immunol.140。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Pathogenesis of SLE: Linkage Analysis of Critical Signaling Pathways
    • 批准号:
      23591450
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      NISHIMURA Hiroyuki
    • 依托单位:
    The establishment of an in vivo system estimating the significance of a responsible gene for murine polygenic dianase model by using ES lines derived thorn the disease model
    • 批准号:
      18390126
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.07万
    • 财政年份:
      2006
    • 负责人:
      NISHIMURA Hiroyuki
    • 依托单位:
    Development of cerebral ischemic model in immune deficiency mouse
    • 批准号:
      16590855
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      2004
    • 负责人:
      NISHIMURA Hiroyuki
    • 依托单位:
    Genetic control of the defective immune tolerance in systemic lupus erythematosus-prone New Zealand Black mice.
    海外基金